Articles
In the pharmaceutical industry, drug packaging is the last critical line of defense for ensuring product quality and patient safety. Faced with increasingly stringent regulatory compliance, cross-contamination, and production efficiency challenges, traditional packaging equipment is no longer sufficient. This article explores the core pain points of modern pharmaceutical packaging and explains why superior packaging machinery must be a stable, intelligent, and verifiable turnkey solution to truly serve as the "invisible guardian" of drug quality. Discover how to build this final barrier for your product.
In the pharmaceutical industry, every pill and every dose carries the weight of life. While we often focus on the R&D and synthesis of active ingredients, we often overlook the f…
In the pharmaceutical industry, every pill and every dose carries the weight of life. While we often focus on the R&D and synthesis of active ingredients, we often overlook the f…
In 2025, clinics and hospitals are rapidly adopting digital tools to improve efficiency and patient care. Healcard stands out as a complete clinic management solution offering electronic health records, smart billing, mobile access, and secure data management. Streamlining daily operations helps doctors save time, reduce errors, and focus more on patients. Healcard isn’t just software; it’s a step toward smarter, more connected healthcare.
Introduction Healthcare’s changing fast. Old-school ways, paper files, long waits, manual billing, they just don’t cut it anymore. Clinics and hospitals now need software that works for them, not against them. It’s 2025, and to deliver good care, you need efficiency, speed, and accuracy. That’s where Healcard steps in. Designed for Indian clinics and hosp…
Introduction Healthcare’s changing fast. Old-school ways, paper files, long waits, manual billing, they just don’t cut it anymore. Clinics and hospitals now need software that works for them, not against them. It’s 2025, and to deliver good care, you need efficiency, speed, and accuracy. That’s where Healcard steps in. Designed for Indian clinics and hosp…
The global Penicillin Active Pharmaceutical Ingredients (API) market was valued at USD 2.95 billion in 2023 and is projected to reach USD 4.79 billion by 2032, growing at a CAGR of 5.6%. This growth is driven by the increasing demand for antibiotics, advancements in manufacturing technologies, and the expansion of healthcare infrastructure in emerging economies. The report provides an in-depth analysis of market trends, key players, and regional dynamics, offering valuable insights for stakeholders in the pharmaceutical industry.
The Penicillin Active Pharmaceutical Ingredients (APIs) market represents a cornerstone of the global pharmaceutical industry, providing the essential building blocks for antibiotics that combat a wide range of bacterial infections. With its critical role in health…
The Penicillin Active Pharmaceutical Ingredients (APIs) market represents a cornerstone of the global pharmaceutical industry, providing the essential building blocks for antibiotics that combat a wide range of bacterial infections. With its critical role in health…
Clinical trials are the backbone of modern medicine but they have historically suffered from a lack of diversity among their participants this has created significant gaps in our understanding of how treatments and medications affect different groups of people this article explores the critical need for diversity in clinical trial recruitment discussing the scientific and ethical reasons behind it, the barriers that prevent it and the strategies being implemented to create a more inclusive and effective future for medical research by ensuring trials are representative of the global population we can improve the safety and efficacy of new therapies for everyone, build greater public trust and move closer to achieving true health equity.
Introduction In the world of medical breakthroughs, cli…
Introduction In the world of medical breakthroughs, cli…
29-Sep-2025
As cannabis research continues to progress, increasing attention is being given to two promising compounds, cannabigerol (CBG) and its precursor, cannabigerolic acid (CBG-A). Often overshadowed by the more widely recognised cannabinoids THC and CBD, these non-psychoactive compounds are now being explored for their therapeutic potential.
As cannabis research continues to progress, increasing attention is being given to two promising compounds, cannabigerol (CBG) and its precursor, cannabigerolic acid (CBG-A). Often overshadowed by the more widely recognised cannabinoids THC and CBD, these non-psychoactive compounds are now being explored for their therapeutic potential. Broughton, a leading UK-based contract research organisation, explores early research on the potential of these cannabinoid…
As cannabis research continues to progress, increasing attention is being given to two promising compounds, cannabigerol (CBG) and its precursor, cannabigerolic acid (CBG-A). Often overshadowed by the more widely recognised cannabinoids THC and CBD, these non-psychoactive compounds are now being explored for their therapeutic potential. Broughton, a leading UK-based contract research organisation, explores early research on the potential of these cannabinoid…
The global Ambulatory EHR Market is projected to grow from USD 6.1 billion in 2023 to USD 10.5 billion by 2032 at a CAGR of 6.3%. Explore market size, major regional trends, deployment shifts toward cloud/web-based models, leading vendors, and what to expect through 2032 in this comprehensive analysis guided by Ameco Research.
In recent years, the healthcare industry has undergone rapid digital transformation. Among its key components is the adoption of Ambulatory EHR (Electronic Health Records in outpatient / ambulatory care settings) systems. These solutions are essential tools for physician offices, specialty clinics, and other outpatient facilities to maintain accurate patient histories, manage clinical workflows, enable remote care protocols, and meet regulatory requirements. As pressu…
In recent years, the healthcare industry has undergone rapid digital transformation. Among its key components is the adoption of Ambulatory EHR (Electronic Health Records in outpatient / ambulatory care settings) systems. These solutions are essential tools for physician offices, specialty clinics, and other outpatient facilities to maintain accurate patient histories, manage clinical workflows, enable remote care protocols, and meet regulatory requirements. As pressu…
Multiple System Atrophy Therapeutics is an evolving field focused on treating a rare neurodegenerative disease with no cure. This article examines the Multiple System Atrophy Therapeutics Market, its size, growth drivers, recent product development, regional trends, key players, and what lies ahead up to 2033—based largely on the report by Acumen Research And Consulting.
What is Multiple System Atrophy and the Role of Therapeutics Multiple System Atrophy (MSA) is a progressive, rare neurodegenerative disorder adversely affecting the autonomic nervous system, movement, balance, coordination, and various bodily functions. Patients experience tremor, parkinsonian symptoms, cerebellar dysfunction, autonomic dysregulation (blood pressure, bladder control), and rapidly declining ability to perfor…
What is Multiple System Atrophy and the Role of Therapeutics Multiple System Atrophy (MSA) is a progressive, rare neurodegenerative disorder adversely affecting the autonomic nervous system, movement, balance, coordination, and various bodily functions. Patients experience tremor, parkinsonian symptoms, cerebellar dysfunction, autonomic dysregulation (blood pressure, bladder control), and rapidly declining ability to perfor…
Explore how to become a research nurse - gain clinical experience, develop trial skills, earn certifications, and enter a career at the forefront of medical innovation.
Research nurses play a pivotal role in bridging clinical care with scientific discovery, offering registered nurses (RNs) a rewarding alternative to traditional nursing. Their work supports the development of new treatments and enhances patient outcomes by conducting clinical trials and ensuring data integrity. Step-by-Step Guide to Becoming a Research Nurse 1. Build Clinical Experience:Begin with at least two years of hands-on nursing, ideally in high-impact areas like oncology, cardiology, or infectious diseases. 2. Develop Key Research Skills:Critical thinking, protocol adherence, data collection, and patient recruitmen…
Research nurses play a pivotal role in bridging clinical care with scientific discovery, offering registered nurses (RNs) a rewarding alternative to traditional nursing. Their work supports the development of new treatments and enhances patient outcomes by conducting clinical trials and ensuring data integrity. Step-by-Step Guide to Becoming a Research Nurse 1. Build Clinical Experience:Begin with at least two years of hands-on nursing, ideally in high-impact areas like oncology, cardiology, or infectious diseases. 2. Develop Key Research Skills:Critical thinking, protocol adherence, data collection, and patient recruitmen…
Richard Corbridge - UK CIO and BCS Fellow
The UK is at a pivotal moment in its digital journey. With more than £40 billion of fresh commitments from global technology leaders like Google, Microsoft, Nvidia, Salesforce and OpenAI, the country has earned a mandate to prove that it can convert tech investment into meaningful, sustainable transformation, according to leading UK CIO and BCS Fellow, Richard Corbridge. Richard Corbridge commented: “The next phase of UK technology growth depends not only on AI algorithms and software, but also on the infrastructure, skills, and trust frameworks that enable them to thrive. Energy resilience, advanced connectivity, and ethical governance will determine…
The UK is at a pivotal moment in its digital journey. With more than £40 billion of fresh commitments from global technology leaders like Google, Microsoft, Nvidia, Salesforce and OpenAI, the country has earned a mandate to prove that it can convert tech investment into meaningful, sustainable transformation, according to leading UK CIO and BCS Fellow, Richard Corbridge. Richard Corbridge commented: “The next phase of UK technology growth depends not only on AI algorithms and software, but also on the infrastructure, skills, and trust frameworks that enable them to thrive. Energy resilience, advanced connectivity, and ethical governance will determine…
23-Sep-2025
In pharmaceutical production, powders often have to be dispersed into liquids. Conventional technology often achieves only incomplete wetting, because the powders are introduced in agglomerated form. One solution is modern vacuum technology, by which the particles can be wetted separately.
The production or refinement of pharmaceutical products often involves dispersing dusty, sticky or fine powders into liquids. When using conventional technology, this often leads to problems - for example, when agglomerated powders are not completely wetted. This is precisely where modern vacuum dispersing systems come in. Pharmaceutical products manufactured on the basis of powders or refined by powders include gels, ointments and suspensions, or tablet coatings. For these products, many di…
The production or refinement of pharmaceutical products often involves dispersing dusty, sticky or fine powders into liquids. When using conventional technology, this often leads to problems - for example, when agglomerated powders are not completely wetted. This is precisely where modern vacuum dispersing systems come in. Pharmaceutical products manufactured on the basis of powders or refined by powders include gels, ointments and suspensions, or tablet coatings. For these products, many di…
Author: Sina Bari, AVP - Medical AI, iMerit Inc
The hype surrounding medical AI often conjures images of powerful algorithms operating out of the clusters of a remote datacenter, but in practice, building clinically-viable technology is far more grounded. For too long, AI followed a linear path: tech firms gathered data, built algorithms, and forced them into clinical workflows. This “black box” approach led to a high rate of failure. Models were often brittle, non-compliant, and could not handle the messiness of real-world patient data. They struggled with fragmented records, nuanced longitudinal histories, or the subjectivity in radiology reports. Today’s bottleneck isn’t compute but clinical validity and regulatory readin…
The hype surrounding medical AI often conjures images of powerful algorithms operating out of the clusters of a remote datacenter, but in practice, building clinically-viable technology is far more grounded. For too long, AI followed a linear path: tech firms gathered data, built algorithms, and forced them into clinical workflows. This “black box” approach led to a high rate of failure. Models were often brittle, non-compliant, and could not handle the messiness of real-world patient data. They struggled with fragmented records, nuanced longitudinal histories, or the subjectivity in radiology reports. Today’s bottleneck isn’t compute but clinical validity and regulatory readin…
Article By Nicolas Wolikow, coFounder at Cure51.
In oncology, progress is often measured in small increments - a few additional months of survival, a slight improvement in quality of life, a percentage point gain in remission rates. While these steps are vital, they reflect an industry norm that focuses overwhelmingly on average patient outcomes. But hidden within the data are remarkable outliers: patients who, against all statistical odds, live far longer and better than expected. These “exceptional survivors” are not anomalies to be brushed aside; they are windows into the biology of resilience. Studying them deeply could reveal the mechanisms that transform certain cancers…
In oncology, progress is often measured in small increments - a few additional months of survival, a slight improvement in quality of life, a percentage point gain in remission rates. While these steps are vital, they reflect an industry norm that focuses overwhelmingly on average patient outcomes. But hidden within the data are remarkable outliers: patients who, against all statistical odds, live far longer and better than expected. These “exceptional survivors” are not anomalies to be brushed aside; they are windows into the biology of resilience. Studying them deeply could reveal the mechanisms that transform certain cancers…
Case management workflow software modernizes pharmacological by digitizing workflows, reducing errors, and ensuring regulatory compliance. It speeds up case processing, improves accuracy, provides audit-ready data, and supports global scalability. By enabling collaboration and data-driven decisions, it transforms PV into a strategic advantage that safeguards patients and strengthens operational efficiency.
Pharmacovigilance (PV) as the cornerstone of drug safety, committed to safeguarding patient health by systematically monitoring, analyzing, and mitigating the risks associated with therapeutic products from pre-clinic stages through post-market oversight.As the innovation pipeline delivers a broader range of therapies, and as global clinical trials and ever-broader regulatory expectations…
Pharmacovigilance (PV) as the cornerstone of drug safety, committed to safeguarding patient health by systematically monitoring, analyzing, and mitigating the risks associated with therapeutic products from pre-clinic stages through post-market oversight.As the innovation pipeline delivers a broader range of therapies, and as global clinical trials and ever-broader regulatory expectations…
The CBH Biospecimen Marketplace is an online biobank and biorepository built for teams who need human biological samples with audit-ready documentation and dependable logistics. Our continuously curated biological specimen inventory exceeds a quarter of a million active units and spans serum, plasma, whole blood, PBMC for research, urine samples, cerebrospinal fluid (CSF), saliva, stool/feces/faeces, swab samples, and human tissue (FFPE and frozen). You can search, filter, compare, and order human biospecimens for research, development, and production—not only RUO feasibility. What differentiates the platform is scientific traceability: standardized preanalytics, transparent biospecimen data, and route-proven cold-chain shipping.
What Counts as a Human Biological Specimen? Human biol…
What Counts as a Human Biological Specimen? Human biol…
Nutrigenomics is reshaping how we understand the connection between genes and diet. This article explores how DNA insights can guide personalized nutrition, improve long-term wellness strategies, and empower individuals to make informed lifestyle choices. With privacy-first, on-device processing, Noorns provides a secure and innovative approach to DNA-based health insights, bridging science and everyday health.
Nutrigenomics, the study of how our genes interact with diet, is emerging as one of the most promising areas in personalized health. Genetic variations can influence how we metabolize nutrients, respond to supplements, and manage risks for chronic conditions. Understanding these patterns opens new opportunities for preventative care, optimized wellness strategies, and more targeted i…
Nutrigenomics, the study of how our genes interact with diet, is emerging as one of the most promising areas in personalized health. Genetic variations can influence how we metabolize nutrients, respond to supplements, and manage risks for chronic conditions. Understanding these patterns opens new opportunities for preventative care, optimized wellness strategies, and more targeted i…
Julie Hurvitz Aliaga, EVP, Innovation, Content and Partnerships, CMI Media Group shares her insights from the recent "Agility: Hype to Hope to Health" event which brought the reality of caregiving into sharp focus. Julie shares practical advice for healthcare marketers around the value of innovation, content and partnerships when speaking to both patients and their caregivers.
The healthcare landscape is undergoing a profound transformation, and at its heart lies an often overlooked, yet absolutely critical, figure: the caregiver. Our recent "Agility: Hype to Hope to Health" event brought this reality into sharp focus during our panel, "The Rise of the Caregiver." It was a privilege to moderate a discussion with such inspiring women – Dr. Robyn Roth, Radiologist and Founder of The Boobie D…
The healthcare landscape is undergoing a profound transformation, and at its heart lies an often overlooked, yet absolutely critical, figure: the caregiver. Our recent "Agility: Hype to Hope to Health" event brought this reality into sharp focus during our panel, "The Rise of the Caregiver." It was a privilege to moderate a discussion with such inspiring women – Dr. Robyn Roth, Radiologist and Founder of The Boobie D…
Design alone is no longer enough to bring transformative products to life. While great design sparks creativity and defines user experience, development is what turns vision into reality. At Hurdle, we believe that true innovation demands more than following a conventional design process-it requires a smarter, more holistic approach that aligns strategy, technology, and market readiness.
A successful design and development process must balance exploration with structure, enabling teams to build high-quality products efficiently while adapting to change along the way. Yet, while the traditional design process may comprise four to five defined phases, Hurdle believes there is more to consider from the outset. Elements such as business analysis, capability planning, budgetary controls, capabil…
A successful design and development process must balance exploration with structure, enabling teams to build high-quality products efficiently while adapting to change along the way. Yet, while the traditional design process may comprise four to five defined phases, Hurdle believes there is more to consider from the outset. Elements such as business analysis, capability planning, budgetary controls, capabil…
ArcaScience, founded by brain cancer survivor Romain Clement, uses AI to transform benefit–risk analysis in drug development. With 100B+ biomedical data points, it helps pharma giants like Sanofi & AstraZeneca speed safer therapies to patients. Fresh off a $7M raise, ArcaScience is expanding in the US, launching patient-facing tools, and setting a new global standard for drug evaluation.
PharmiWeb Q&A - Romain Clement Sept 2025 1. Let’s start with the big picture — what inspired the founding of ArcaScience, and what core mission drives the company today? ArcaScience has its roots in a very personal journey. Years ago, I was diagnosed with a form of brain cancer and came face-to-face with how hard it is to design treatments truly adapted to individual patients. After my recovery, I bec…
PharmiWeb Q&A - Romain Clement Sept 2025 1. Let’s start with the big picture — what inspired the founding of ArcaScience, and what core mission drives the company today? ArcaScience has its roots in a very personal journey. Years ago, I was diagnosed with a form of brain cancer and came face-to-face with how hard it is to design treatments truly adapted to individual patients. After my recovery, I bec…
Analytical method development and validation are essential for CRDMO success, ensuring accurate, reliable, and regulatory-compliant results from R&D to GMP manufacturing. Pharmaffiliates integrates ISO 17025-accredited lab services into its CRDMO model, offering capabilities like HPLC, LC-MS/MS, impurity profiling, stability testing, and method transfer. Validated methods enable consistent batch quality, faster scale-up, and streamlined regulatory compliance, helping clients accelerate drug development with confidence.
The Role of Analytical Method Development in CRDMO Success Why Analytics Is a Pillar of Pharmaceutical Development In today’s pharmaceutical environment, where compliance and speed-to-market are paramount, analytical method development and validation play a foun…
The Role of Analytical Method Development in CRDMO Success Why Analytics Is a Pillar of Pharmaceutical Development In today’s pharmaceutical environment, where compliance and speed-to-market are paramount, analytical method development and validation play a foun…
The United States Food and Drug Administration’s (FDA’s) Accelerated Approval (AA) pathway, initially established in 1992 during the HIV/AIDS epidemic to provide faster access to life-saving treatments, has been instrumental in expediting access to therapies for serious and life-threatening conditions. It is particularly significant in therapeutic areas, such as rare diseases, where surrogate or intermediate clinical endpoints may be necessary due to limited patient populations or slow disease progression. While this approach has encouraged innovation, it has also raised concerns about drugs staying on the market without confirmed evidence of their effectiveness.
The United States Food and Drug Administration’s (FDA’s) Accelerated Approval (AA) pathway, initially established in 1992 during…
The United States Food and Drug Administration’s (FDA’s) Accelerated Approval (AA) pathway, initially established in 1992 during…
